Showing results (891-900 of 977) with videos related to
Sort By:
Pageof 98
NPJ Breast Cancer|June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.NPJ Breast Cancer|May 24, 2023
Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancerStefania Morganti, Heather A Parsons, Nancy U Lin, et al.NPJ Breast Cancer|July 3, 2020
Histopathologic, immunophenotypic, and proteomics characteristics of low-grade phyllodes tumor and fibroadenoma: more similarities than differencesLingxin Zhang, Chen Yang, John D Pfeifer, et al.NPJ Breast Cancer|April 24, 2021
Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analysesPei Sze Ng, Jia Wern Pan, Muhammad Mamduh Ahmad Zabidi, et al.NPJ Breast Cancer|May 17, 2023
Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancerYuli Chen, Haojia Li, Andrew Janowczyk, et al.NPJ Breast Cancer|March 23, 2023
Predicting breast cancer types on and beyond molecular level in a multi-modal fashionTianyu Zhang, Tao Tan, Luyi Han, et al.NPJ Breast Cancer|August 23, 2022
ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistanceAntonio Strillacci, Pasquale Sansone, Vinagolu K Rajasekhar, et al.NPJ Breast Cancer|August 9, 2022
Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancerMasanori Oshi, Ankit Patel, Rongrong Wu, et al.NPJ Breast Cancer|November 7, 2022
Molecular differences between younger versus older ER-positive and HER2-negative breast cancersTao Qing, Thomas Karn, Mariya Rozenblit, et al.NPJ Breast Cancer|May 6, 2021
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancerAnthony Goncalves, Pascal Finetti, Daniel Birnbaum, et al.Pageof 98